Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Jun 1.

Published in final edited form as: Atherosclerosis. 2010 Jan 4;210(2):671–673. doi: 10.1016/j.atherosclerosis.2009.12.034

Table 1.

Clinical and laboratory characteristics at baseline between progressors and non-progressors.

	Progressors N = 206	Non-progressors N = 980	P
Age (years)	44 ± 8	37 ± 9	<.0001
Male (%)	65	41	<.0001
Type 1 diabetes (%)	67	40	0.03
Smoking current (%)	12	7	0.03
Smoking ever (%)	22	19	0.31
BMI (kg/m²)	27 ± 4	25 ± 4	<.0001
Systolic BP (mm Hg)	123 ± 13	114 ± 12	<.0001
Diastolic BP (mm Hg)	80 ± 9	77 ± 8	<.0001
CVS at baseline (mm³)	7.16 ± 9.44	0.76 ± 2.39	<.0001
Total cholesterol (mg/dl)	185 ± 39	184 ± 37	0.60
HDL cholesterol (mg/dl)	51 ± 16	54 ± 15	0.04
LDL cholesterol (mg/dl)	110 ± 32	108 ± 32	0.40
Triglycerides (mg/dl)	102 (32-758)	93 (25-1060)	0.03
HbA1c (%)	7.3 ± 1.5	6.4 ± 1.5	<.0001
AER (mg/L)	11 (1,0-4059)	1,1 (0,5-1919)	<.0001
Statin use (%)	25	8	<.0001
Fibrinogen (mg/dl)	276 ± 61	259 ± 61	0.0003

Data are means ± SD, % or geometric means (range). BMI: body mass index; BP: blood pressure; CVS: calcium volume score; AER: albumin excretion rate.